Skip to main content

VEGF and Cancer

  • Book
  • © 2004

Overview

Part of the book series: Medical Intelligence Unit (MIUN)

Buy print copy

Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

About this book

VEGF and Cancer is a comprehensive and up to date review of current knowledge on the role of vascular endothelial growth factor (VEGF) in cancer.
Key Features:
-Discussion of VEGF as potent angiogenic factor and its role in tumor angiogenesis,
-Review of the biology, molecular properties and regulation of VEGF,
-Discussion of the role of VEGF in a range of different tumor types, both solid tumors and haematological cancers,
-Review of the therapeutic potential of different approaches to block VEGF,
-Review of recent evidence that in addition to its role as an endothelial cell mitogen, VEGF may also be an autocrine growth factor for tumor cells, regulating survival and invasion.

This book is aimed at scientists new to angiogenesis and VEGF biology and provides new information for established researchers and scientists. It will also be a useful text for clinicians interested in anti-angiogenic therapy for treatment of human cancers.

Editors and Affiliations

  • Beaumont Hospital Dept. Surgery, Royal College of Surgeons, Ireland Education and Research Centre, Dublin 9, Ireland

    Judith H. Harmey

Bibliographic Information

  • Book Title: VEGF and Cancer

  • Editors: Judith H. Harmey

  • Series Title: Medical Intelligence Unit

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 2004

  • Hardcover ISBN: 978-0-306-47988-5Published: 26 May 2004

  • Softcover ISBN: 978-1-4613-4810-8Published: 30 October 2012

  • Edition Number: 1

  • Number of Pages: XVII, 167

Publish with us